Renal Cancer  >>  Tookad (padeliporfin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tookad (padeliporfin) / ImPact Biotech
NCT01573156 / 2011-003311-27: Vascular Targeted Photodynamic Therapy T1a Renal Tumours

Terminated
2a
5
Europe
Light activated WST11, Tookad Soluble
University of Oxford, Steba Biotech S.A.
Renal Cancer
05/14
06/15

Download Options